Depression(stherapie) – ein Feld der Integration?

Wer hätte gedacht, dass uns die Wirklichkeit auf eine solche Weise mit dem Thema Depression konfrontieren würde, wie es durch die Corona-Pandemie geschieht? Viele Menschen sind Belastungen ausgesetzt, haben berufliche und familiäre Sorgen, Zukunftsängste – typische Faktoren, die ein Anwachsen depressiver Erkrankungen erwarten lassen.

Publication History

Article published online:
27 August 2021

• Literatur

• 1 Damerow S, Rommel A, Prütz F. et al. Die gesundheitliche Lage in Deutschland in der Anfangsphase der COVID-19-Pandemie. Zeitliche Entwicklung ausgewählter Indikatoren der Studie GEDA 2019/2020-EHIS. Journal of Health Monitoring 2020; 5 (04) 3-22
• 2 Hapke U, Cohrdes C, Nübel J. Depressive Symptomatik im europäischen Vergleich – Ergebnisse des European Health Interview Survey (EHIS) 2. J Health Monitoring 2019; 4 (04) 62-70
• 3 Global Burden of Diseases: Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1789-1858 Epub 2018 Nov 8
• 4 Statistisches Bundesamt. https://www.destatis.de/DE/Themen/Gesellschaft-Umwelt/Gesundheit/Todesursachen/Tabellen/suizide.html
• 5 Twenge JM, Martin GN, Campbell WK. Decreases in psychological well-being among American adolescents after 2012 and links to screen time during the rise of smartphone technology. Emotion 2018; 18: 765-780
• 6 Wang Y, Kala MP, Jafar TH. Factors associated with psychological distress during the coronavirus disease 2019 (COVID-19) pandemic on the predominantly general population: A systematic review and meta-analysis. PLoS One 2020; 15 (12) 0
• 7 Beck AT, Bredemeier KA. unified model of depression: Integrating clini-cal, cognitive, biological, and evolutionary perspectives. Clin Psychol Sci 2016; 4 (04) 596-619
• 8 Hoffmann A, Sportelli V, Ziller M. et al. Epigenomics of Major Depressive Disorders and Schizophrenia: Early Life Decides. Int J Mol Sci 2017; 18 (08) 1711
• 9 Moore SR, Depue RA. Neurobehavioral foundation of environmental reactivity. Psychol Bull 2016; 142 (02) 107-64
• 10 Benedetti F, Riccaboni R, Poletti S. et al. The serotonin transporter genotype modulates the relationship between early stress and adult suicidality in bipolar disorder. Bipolar Disord 2014; 16 (08) 857-66
• 11 Caspi A, Sugden K, Moffitt TE. et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386-389
• 12 Border R, Johnson EC, Evans LM. et al. No Support for Historical Candidate Gene or Candidate Gene-by-Interaction Hypotheses for Major Depression Across Multiple Large Samples. Am J Psychiatry 2019; 176 (05) 376-387
• 13 Schauenburg H. Depression und Bindung – Therapeutische Strategien. Göttingen: Vandenhoeck und Ruprecht; 2018
• 14 Fearon P, Shmueli-Goetz Y, Viding E. et al. Genetic and environmental influences on adolescent attachment. J Child Psychol Psychiatry 2014; 55 (09) 1033-1041
• 15 Cipriani A, Furukawa TA, Salanti G. et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 2018; 391: 1357-1366
• 16 Bschor T, Hullmeine L. Pharmakotherapie der Depression - neue Erkenntnisse und neue Strategien. PiD – Psychotherapie im Dialog 2021; 22 (03) 49-53
• 17 Kappelmann N, Arloth J, Georgakis MK. et al. Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms: A Genetic Correlation and 2-Sample Mendelian Randomization Study. JAMA Psychiatry 2021; 78: 161-170
• 18 Maslej MM, Furukawa TA, Cipriani A. et al. Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials. JAMA Psychiatry 2021; 78: 490-497
• 19 Reiff CM, Richman EE, Nemeroff CB. et al. the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research. Psychedelics and Psychedelic-Assisted Psychotherapy. Am J Psychiatry 2020; 177: 391-410
• 20 Davis AK, Barrett FS, May DG. et al. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. JAMA Psychiatry 2021; 78: 481-489
• 21 Cuijpers P, Karyotaki E, de Wit L. et al. The effects of fifteen evidence-supported therapies for adult depression: A meta-analytic review. Psychother Res 2020; 30: 279-293
• 22 Schwartz B, Cohen ZD, Rubel JA. et al. Personalized treatment selection in routine care: Integrating machine learning and statistical algorithms to recommend cognitive behavioral or psychodynamic. therapy, Psychother Res 2021; 31 (01) 33-51 Epub 2020 May 28
• 23 Driessen E, Hegelmaier LM, Abbass AA. et al. The efficacy of short-term psychodynamic psychotherapy for depression: A meta-analysis update. Clin Psychol Rev 2015; 42: 1-15
• 24 Høstmælingen A, Ulvenes P, Nissen-Lie A. et al. Comparing outcomes in chronic depression following inpatient psychotherapy for patients continuing versus discontinuing antidepressant medication. Clin Psychol Psychother. 2021
• 25 Rost F, Luyten P, Fearon P. et al. Personality and outcome in individuals with treatment-resistant depression-Exploring differential treatment effects in the Tavistock Adult Depression Study (TADS). J Consult Clin Psychol 2019; 87: 433-445
• 26 Leuzinger-Bohleber M, Hautzinger M, Fiedler G. et al. Outcome of Psychoanalytic and Cognitive-Behavioural Long-Term Therapy with Chronically Depressed Patients: A Controlled Trial with Preferential and Randomized Allocation. Can J Psychiatry 2019; 64: 47-58
• 27 Multmeyer J. Ambulante psychotherapeutische Versorgung in Deutschland – eine Kohortenbetrachtung der KBV. Projekt Psychotherapie 2014; 2: 12-22
• 28 Young JE, Klosko JS, Weishaar ME. Schematherapie. Ein praxisorientiertes Handbuch. Paderorn: Junfermann Verlag; 2008
• 29 Backenstrass M. Neuere Ansätze in der Psychotherapie der chronischen Depression. PiD – Psychotherapie im Dialog 2021; 22 (03) 24-28
• 30 Hayes SC, Strosahl KD, Wilson KG. Akzeptanz und Commitment Therapie. Ein erlebnisorientierter Ansatz zur Verhaltensänderung. München: CIP-Medien; 2004
• 31 Greenberg LS, Watson JC. Emotion-focused therapy for depression. Washington, DC: American Psychological Association; 2005
• 32 Bateman AW, Fonagy P. Psychotherapie der Borderline Persönlichkeitsstörung. Ein mentalisierungsgestütztes Behandlungskonzept. Gießen: Psychosozialverlag; 2008
• 33 Rudolf G. Strukturbezogene Psychotherapie. 4 Aufl.. Stuttgart: Schattauer; 2020
• 34 Schauenburg H, Teismann T. Psychotherapie der Depression. In: Senf W, Broda M. Hrsg. Lehrbuch der Psychotherapie. 4. Aufl.. Stuttgart: Thieme; 2020: 481-509
• 35 Dinger U, Schauenburg H. Therapie depressiver Störungen. In: Rief W, Schramm E, Strauß B. Hrsg. Psychologische Psychotherapie. München: Elsevier; 2021: 77-94
• 36 Tyrer P. Personality disorder: Good reasons to reclassify. Aust N Z J Psychiatry 2017; 51: 1077-1078
• 37 Meyer G, Schultz J-H. Depression per App behandeln? Möglichkeiten und Grenzen digitaler Gesundheitsanwendungen (DiGAs). PiD – Psychotherapie im Dialog 2021; 22 (03) 54-58
• 38 Huber J, Jennissen S, Nikendei C. et al. Agency and Alliance as Mechanisms of Change in Psychotherapy. J Consul Clin Psychol 2021; 89: 214-226
• 39 Safran JD, Muran JC, Eubanks-Carter C. Repairing alliance ruptures. Psychotherapy 2011; 48: 80-87
• 40 Zilcha-Mano S, Goldstein P, Dolev-Amit T. et al. Oxytocin synchrony between patients and therapists as a mechanism underlying effective psychotherapy for depression. J Consult Clin Psychol 2021; 89: 49-57